Obstructive Sleep Apnea (OSA) is a risk factor for both atrial fibrillation (AF) and atrial flutter (AFL). Non-pulmonary triggershave been described in patients with OSA.
Patients suffering with Paroxysmal Atrial Fibrillation refractory to antiarrythmic medications are commonly treated with catheter radiofrequency-ablation. The most common location for ablation for AF would be the pulmonary veins as it approaches the left atrium. This has been the conventional ablation site. Another catheter based technique known has Posterior Wall Isolation (PWI), is also routinely used. Here, the posterior wall of the left atrium is ablated. PWI has shown mild efficacy in reducing recurrence rates of AF in patients without OSA. There has been work looking at the efficacy of radiofrequency ablation in patients with OSA. Following a review of the literature, we found that radiofrequency ablation was less effective in reducing recurrence of AF in OSA patients compared to control. There appeared to be a two-way relationship, however, where a return to sinus rhythm following catheter ablation, led to a decreased median AHI score or severity of sleep apnea.
In this study, we hoped to replicate these findings, looking at the recurrence of AF and AFL in OSA patients compared to controlusing the conventional pulmonary vein ablation site. We also wanted to compare the efficacy of posterior wall isolation inpatients with sleep apnea, compared to control in patients who have Paroxysmal Atrial Fibrillation.